Asthma and Allergies

Drugs for Asthma and Allergies

  • Overview of medications used in the treatment of asthma and allergies:

    • Short Acting Beta Agonists

    • Inhaled Corticosteroids

    • Long Acting Beta Agonists

    • Leukotriene Modifiers

    • Systemic Corticosteroids

    • Methylxanthines

    • Antihistamines

    • Corticosteroid Nasal Sprays

    • Mast Cell Stabilizers

    • Ophthalmic agents (e.g., NSAID, Steroid, Antihistamine)

Asthma Control Objectives

  • Aiming to achieve the following outcomes in asthma management:

    • Prevent chronic and troublesome symptoms such as:

    • Coughing or breathlessness during the night, daytime, or after exertion.

    • Maintain (near) normal pulmonary function.

    • Maintain normal activity levels, including exercise and attending school or work.

    • Require infrequent use of inhaled short-acting β2-agonist for quick symptom relief (not including prevention of exercise-induced bronchospasm).

    • Meet patients’ and families’ expectations regarding asthma care.

    • Prevent recurrent exacerbations and minimize emergency department visits or hospitalizations.

    • Preserve lung function and prevent reduced lung growth in children.

    • Provide optimal pharmacotherapy with minimal or no adverse effects.

  • Source: Adapted from the National Institutes of Health, National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program (NAEPP), 2007.

Overview of Asthma

  • Definition:

    • Chronic inflammatory disease of the airways characterized by:

    • Obstruction due to bronchoconstriction, edema, and excessive mucus production.

  • Symptoms include:

    • Wheezing

    • Coughing

    • Shortness of breath

    • Chest tightness

Exercise-Induced Bronchospasm (EIB)

  • Characteristics:

    • Symptoms may not be present at other times.

    • Onset occurs during exercise and lasts for 20 to 60 minutes afterward.

    • Peak bronchospasm typically occurs within the first 5 to 15 minutes of exercise.

    • Symptoms are similar to those of chronic asthma.

Pathology of Asthma

  • Normal airway vs. asthmatic airway differences:

    • Normal airway:

    • Relaxed smooth muscles, unobstructed airflow.

    • Asthmatic airway:

    • Wall inflammation and thickening.

    • During an asthma attack, airway tissues become constricted and inflamed.

Chemical Mediators in Asthma

  • Membrane Bound Arachidonic Acid involved in:

    • Breakdown by Phospholipase A2 into several mediators:

    • Prostaglandins

    • Thromboxanes

    • Leukotrienes

    • Prostacyclin

  • Other mediators include:

    • Histamine

    • Platelet-activating factor

    • Cytokines

  • Mixed activity of these mediators can:

    • Cause either bronchoconstriction or bronchodilation.

Asthma Triggers

  • Common triggers include:

    • Pet allergens

    • Dust mites

    • Fungal spores

    • Infections

    • Tobacco smoke

    • Pollen

    • Chemical exposure

    • Comorbid conditions (additional health problems).

Asthma Classification

Intermittent Asthma

  • Symptoms occur no more than:

    • 2 days/week

    • Night awakenings: no more than 2 times/month.

    • Rescue inhaler use: no more than 2 times/week.

    • No interference with normal activity.

    • Normal lung function indicators.

    • Fewer than 2 exacerbations/year requiring oral corticosteroids.

Mild Persistent Asthma

  • Symptoms occur:

    • More than 2 days/week but not daily.

    • Night awakenings 3 to 4 times/month.

    • Rescue inhaler use more than 2 times/week (not daily, not more than once/day).

    • Minor activity limitations.

    • Abnormal lung function with 2 or more exacerbations/year needing oral corticosteroids.

Moderate Persistent Asthma

  • Symptoms are:

    • Daily occurrence.

    • Night awakenings more than once/week but not nightly.

    • Daily rescue inhaler use with some activity limitations.

    • Abnormal lung function indicators with 2 or more exacerbations/year requiring oral corticosteroids.

Severe Persistent Asthma

  • Symptoms persist:

    • Throughout the day.

    • Night awakenings are often daily.

    • Rescue inhaler use several times/day.

    • Significant activity limitations.

    • Abnormal lung function with 2 or more exacerbations/year requiring oral corticosteroids.

Asthma Management Steps

  • Step 1: Intermittent asthma

    • Preferred: Short-Acting Beta Agonist (SABA) as needed.

  • Step 2: Mild persistent asthma

    • Preferred: Low-dose Inhaled Corticosteroid (ICS).

  • Step 3: Moderate persistent asthma

    • Preferred: Medium-dose ICS + Long-Acting Beta Agonist (LABA).

    • Alternative: Low-dose ICS + either Leukotriene receptor antagonists (LTRA) or Theophylline.

  • Step 4: Severe persistent asthma

    • Preferred: High-dose ICS + LABA.

    • Consultation with asthma specialist is advised.

  • Step 5: Higher treatment intensity if needed.

  • Step 6: Adjust medication based on control and symptoms.

    • Each step includes patient education and monitoring environmental factors.

Inhalers and Spacers

  • Local delivery benefits include:

    • Better pharmacokinetic parameters.

    • Avoidance of gastrointestinal absorption, first-pass effect, and systemic distribution.

  • Importance of proper technique in effective therapy.

Peak Flow Meters

  • Purpose and Usage:

    • Allows patients to monitor peak expiratory flow (PEF).

    • Determine personal best PEF during a controlled asthma period.

    • Decreased PEF may indicate imminent asthma attacks.

    • Pre-established management plan for PEF decreases is necessary.

Quick-Relief Drugs

  • Function: Treat symptoms of acute asthma attacks and prevent imminent attacks.

    • Not used on a routine basis; available for all asthma patients.

    • Rapid onset inhaled β2-agonist is the primary medication.

Adrenergic Receptors

  • Types:

    • β1 receptors:

    • Heart effects: Increase heart rate, myocardial contractility, and conduction velocity as well as renin release from kidneys.

    • β2 receptors:

    • Bronchi: Bronchodilation.

    • Skeletal muscle: Stimulate contraction.

    • Liver: Glycogenolysis and gluconeogenesis.

Short-Acting β2-Agonists

  • Primary medications for acute attacks:

    • Onset of action within 5 minutes and duration between 2 to 6 hours.

    • Albuterol is the most frequently used.

    • Frequent use prior to exercise requires reevaluation of long-term therapy.

Anticholinergics

  • Mechanism: Inhibition of cholinergic receptors in the parasympathetic nervous system.

    • Induce bronchodilation but are less effective than β2-agonists.

    • Not commonly used for asthma, but can assist during acute attacks and are effective in COPD (e.g., Ipratropium).

Systemic Corticosteroids

  • Function: Anti-inflammatory activity.

    • Not routinely used, but can be combined with SABA in specific situations (e.g., Methylprednisolone, Prednisone, Dexamethasone).

Long-Term Therapy for Asthma

  • Purpose: Reducing the incidence of acute attacks via scheduled medication therapy.

  • Available options:

    • Inhaled corticosteroids

    • Long-acting β2-agonists

    • Mast cell stabilizers

    • Leukotriene modifiers

    • Methylxanthines

Inhaled Corticosteroids

  • Mainstay of long-term therapy:

    • Preferred for persistent asthma.

    • Decreases frequency/severity of attacks and improves nocturnal asthma control.

    • Can increase dose or add LABA for worsening asthma symptoms.

Common Inhaled Corticosteroids and Dosing Details

  • Drug Name / Dosage Form / Dosing Interval:

    • Fluticasone (Flovent): MDI, 2 times/day.

    • Budesonide (used in combination): DPI, 2 times/day.

    • Flunisolide (Aerobid): MDI, 2 times/day.

Inhaled Corticosteroids: Adverse Effects

  • Local Effects:

    • Hoarseness, cough, thrush; minimized by using spacer and rinsing mouth after use.

  • Systemic Effects:

    • Growth suppression in children, decreased bone mineralization, and risk of cataracts.

Long-Acting β-Agonists

  • Inhaled bronchodilators with extended-release oral tablets available:

    • Slower onset than short-acting agonists.

    • Not for rescue therapy.

    • Beneficial in reducing rescue inhaler use and nocturnal asthma symptoms.

Common Long-Acting β-Agonists & Dosing

  • Drug Name / Dosage Form / Dosing Interval:

    • Salmeterol (Serevent): DPI, every 12 hours.

    • Formoterol: DPI, every 12 hours.

    • Albuterol: Extended release oral tablets, every 12 hours.

Leukotriene Modifiers (Montelukast)

  • Oral medications used for long-term therapy:

    • Not for rescue therapy.

    • Inhibit synthesis or activity of leukotrienes.

    • Recommended for persistent asthma; preferred or alternate treatment for children under 11.

Methylxanthines

  • Theophylline as an oral bronchodilator:

    • Not the preferred asthma treatment due to narrow therapeutic index.

    • Requires blood level monitoring and shows moderate effectiveness.

Role of the Athletic Trainer in Asthma Management

  • Key responsibilities include:

    • Patient education on asthma and medication usage.

    • Monitoring compliance and overall effectiveness of medications.

    • Use of inhalers, spacers, and peak flow meters.

    • Managing asthma symptoms.

Monitoring Asthma Effectiveness

  • Assessing the use of rescue medication:

    • Excessive usage may indicate poor asthma control requiring reevaluation of long-term therapy.

    • A stepwise approach is essential for managing asthma effectively.

Exercise-Induced Bronchospasm Management

  • Recommendations:

    • Use quick-relief medication 5 to 15 minutes before exercise.

    • Additional puffs may be necessary if symptoms arise during exercise.

    • Frequent symptoms necessitate evaluation of long-term therapy strategies.

Educating Athletes about Peak Flow Meters

  • Educate on proper use for monitoring PEF:

    • Establish a personal best during a controlled asthma period.

    • Monitor for decreases indicating airflow obstruction and set management plans with a physician.

Overview of Allergies

  • General information on allergens and their effects on individuals.

Sensitization to an Allergen

  • Details on how individuals may become sensitized to allergens, referencing primary sources.

Response to an Allergen

  • Outline of physiological and symptomatic responses associated with allergens, citing relevant literature.

Antihistamines

  • Function: Block the action of histamine via different receptors:

    • H1: Found in respiratory tract and peripheral blood vessels.

    • H2: Found in the GI tract.

    • H3: Found in the CNS.

Types of Antihistamines

  • First Generation:

    • Diphenhydramine (Benadryl)

    • Chlorpheniramine (Chlor-Trimeton)

    • Doxylamine (Unisom)

  • Second Generation:

    • Loratadine (Claritin)

    • Cetirizine (Zyrtec)

    • Fexofenadine (Allegra)

    • Desloratadine (Clarinex)

    • Levocetirizine (Xyzal)

Antihistamines: Adverse Effects

  • First-generation antihistamines can cause:

    • Sedation, slowed reaction time, "hangover effect," and paradoxical excitation.

    • Anticholinergic effects including dry mouth, urinary retention, blurred vision, tachycardia, reduced sweating, and constipation.

Corticosteroids

  • Topical Corticosteroids:

    • Used in nasal sprays for allergic rhinitis.

    • Inhibit production of inflammatory mediators and alleviate symptoms such as runny nose, itching, and sneezing.

  • Oral Corticosteroids:

    • Indicated for use in severe allergic symptoms; potential for adverse effects exists.

Nasal Corticosteroids

  • Characteristics:

    • Slower onset of action; benefits seen in 1 to 3 days with maximal effects in 2 to 3 weeks.

    • Most effective when used for several weeks prior to and during exposure to allergens.

    • Minor adverse effects exist, and systemic effects are rare.

Mast Cell Stabilizers

  • Action: Decrease release of histamine in response to allergens.

    • Example: Cromolyn (Nasalcrom) as an OTC nasal spray, typically dosed 3 to 4 times/day.

    • Generally less effective than corticosteroids; may cause nasal irritation.

Ocular Inflammation Treatment for Allergies

  • Various systemic and ophthalmic medications are available:

    • Antihistamines

    • Corticosteroids

    • Decongestants

    • Mast cell stabilizers

    • NSAIDs.

Ophthalmic Products

  • Categories and examples:

    • Antihistamine: Olopatadine (Patanol, Rx)

    • Corticosteroid: Dexamethasone (Dexasol, Rx)

    • Mast cell stabilizer: Nedocromil (Alocril, Rx)

    • NSAID: Ketorolac (Acular, Rx)

    • Ophthalmic decongestant: Oxymetazoline (Visine L.R., OTC)

Role of the Athletic Trainer in Allergy Management

  • Responsibilities include monitoring effectiveness of treatments, educating proper medication usage, and distinguishing between allergy and cold symptoms.

  • Engagement in non-drug therapy and prevention strategies to support patient health.